Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

Accelerate Diagnostics, Inc (AXDX) Stock Forecast 2025 - AI Price Prediction & Analysis

Accelerate Diagnostics, Inc (AXDX) AI Stock Price Forecast & Investment Analysis

Accelerate Diagnostics, Inc Stock Price Chart and Technical Analysis

Loading Accelerate Diagnostics, Inc interactive price chart and technical analysis...

Accelerate Diagnostics, Inc (AXDX) - Comprehensive Stock Analysis & Investment Research

Company Overview & Business Profile

Accelerate Diagnostics, Inc (Stock Symbol: AXDX) is a leading company in the Industrial Applications and Services sector , specifically operating within the Laboratory Analytical Instruments industry. The organization employs approximately 184 professionals worldwide . The company has established itself as an emerging investment opportunity with substantial growth potential.

Financial Performance & Key Metrics Analysis

Annual Revenue: $8 million generating a -436.6% net profit margin .

Market Capitalization: $0 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -337.3% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Advanced AI Stock Prediction & Price Target Analysis

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Accelerate Diagnostics, Inc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Market Position & Competitive Advantage Analysis

Accelerate Diagnostics, Inc strategically competes in the highly dynamic Laboratory Analytical Instruments marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities . . The company maintains a healthy 24.6% gross margin, indicating strong pricing power and operational efficiency.

Accelerate Diagnostics, Inc (AXDX) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Accelerate Diagnostics, Inc stock analysis.

Loading Accelerate Diagnostics, Inc comprehensive fundamental analysis and insider trading data...

Deep dive into Accelerate Diagnostics, Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Accelerate Diagnostics, Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Accelerate Diagnostics, Inc: With a P/E ratio of -0.21, the market sees the stock as potentially undervalued.

P/E Ratio -0.21x
Market Cap $0M
EPS $-4.21
Book Value/Share $-2.22
Revenue/Share $0.03
FCF/Share $-1.00
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Accelerate Diagnostics, Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Accelerate Diagnostics, Inc: An ROE of -337.3% indicates room for improvement in shareholder value creation.

ROE -337.3%
ROA -83.0%
ROIC -47.9%
Gross Margin 24.6%
Operating Margin -508.4%
Net Margin -436.6%
EBT Margin -553.1%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Accelerate Diagnostics, Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Accelerate Diagnostics, Inc: A current ratio of 7.44 indicates strong liquidity.

Current Ratio 7.44x
Quick Ratio 6.39x
D/E Ratio 2.09x
Financial Leverage 3.23x
Interest Coverage -4.5x
Working Capital $75M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Accelerate Diagnostics, Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Accelerate Diagnostics, Inc: Free cash flow of $-48M indicates cash challenges that need attention.

Operating Cash Flow $-47M
Free Cash Flow $-48M
Capital Spending $-1M
FCF/Sales -389.5%
CapEx/Sales 5.1%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Accelerate Diagnostics, Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Accelerate Diagnostics, Inc: An asset turnover of 0.15x suggests room for improvement in asset utilization.

Asset Turnover 0.15x
Receivables Turnover 6.0x
Inventory Turnover 1.7x
Fixed Assets Turnover 1.5x
Days Sales Outstanding 61 days
Days Inventory 220 days
Payables Period 67 days
Cash Conversion Cycle 214 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Accelerate Diagnostics, Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Accelerate Diagnostics, Inc: With annual revenue of $8M, Accelerate Diagnostics, Inc represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $8M
Operating Income $-38M
Net Income $-53M
R&D Expense $18M
SG&A Expense $375M
Cost of Goods Sold $9M
Balance Sheet Highlights ($ Millions)
Total Current Assets $87M
Cash & Short-term Investments $72M
Total Liabilities $181M
Short-term Debt $0M
Accounts Receivable $3M
Inventory $8M
Dividend & Shareholder Information
Shares Outstanding 25M
Growth Metrics (YoY)
EPS Growth -318.9%

Latest Accelerate Diagnostics, Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Accelerate Diagnostics, Inc (AXDX) stock price and investment outlook.

, source: MarketWatch

Company Profile Accelerate Diagnostics Inc. 3950 South Country Club Road 4th floor, Suite 470 Tucson, Arizona 85714 Phone1 520 365-3100 IndustryMedical Equipment/Supplies SectorHealth Care/Life ...

Accelerate Diagnostics, Inc Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Accelerate Diagnostics, Inc against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
A Unlock Forecast $34077M 29.2x 5.6x
AKYA Unlock Forecast $64M -2.1x -10.9x
ASTC Unlock Forecast $8M 28.9x 0.3x
AVTR Unlock Forecast $9050M 13.2x 1.4x
AXDX Unlock Forecast $0M -0.2x 0.0x
BIO Unlock Forecast $8382M 26.3x 1.2x
BIO-B Unlock Forecast $6816M 21.4x 1.0x
BNGO Unlock Forecast $16M 0.0x 0.3x
BRKR Unlock Forecast $6145M 28.3x 3.2x
CTKB Unlock Forecast $530M 82.0x 1.4x
EYPT Unlock Forecast $815M -4.4x 3.3x
HBIO Unlock Forecast $22M -8.3x 1.4x
ILMN Unlock Forecast $15746M 12.5x 7.0x
LAB Unlock Forecast $475M -2.4x 1.1x
LCTC Unlock Forecast $9M x 1.5x
MTD Unlock Forecast $24913M 31.5x -136.9x
NAUT Unlock Forecast $89M -3.8x 0.5x
OMIC Unlock Forecast $50M -1.7x 0.4x
PACB Unlock Forecast $414M -1.5x 6.7x
PRPO Unlock Forecast $22M -1.2x 0.6x
QTRX Unlock Forecast $209M -11.1x 0.7x
RPID Unlock Forecast $123M -0.9x 2.3x
RVTY Unlock Forecast $11193M 39.3x 1.5x
SEER Unlock Forecast $134M -2.0x 0.4x
TXG Unlock Forecast $1777M -8.6x 2.3x
WAT Unlock Forecast $17843M 27.0x 8.3x

Frequently Asked Questions - Accelerate Diagnostics, Inc Stock Forecast

How accurate are Accelerate Diagnostics, Inc stock predictions?

Our AI model demonstrates 33% historical accuracy for AXDX predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Accelerate Diagnostics, Inc stock price forecasts?

Our analysis considers Accelerate Diagnostics, Inc's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Accelerate Diagnostics, Inc a good investment in 2025?

Based on our AI analysis, Accelerate Diagnostics, Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Accelerate Diagnostics, Inc forecasts updated?

Accelerate Diagnostics, Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Accelerate Diagnostics, Inc Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Accelerate Diagnostics, Inc stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...